|
|
||||||||
Degradation Are Regulated by ZAP-701



* Institut National de la Santé et de la Recherche Médicale, Unité 520, Institut Curie, and
Molecular Immunology Unit, Institut Pasteur, Paris, France; and
Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA 02215
TCR down-modulation following binding to MHC/peptide complexes is
considered to be instrumental for T cell activation because it allows
serial triggering of receptors and the desensitization of stimulated
cells. We studied CD3/TCR down-modulation and
degradation in T
cells from two ZAP-70-immunodeficient patients. We show that, at high
occupancy of the TCR, down-modulation of the CD3/TCR is comparable
whether T cells express or do not express ZAP-70. However, if TCR
occupancy was low, we found that CD3/TCR was down-regulated to a lesser
extent in ZAP-70-negative than in ZAP-70-positive T cells. We studied
CD3/TCR down-modulation in P116 (a ZAP-70-negative Jurkat cell-derived
clone) and in P116 transfected with genes encoding the wild-type or a
kinase-dead form of ZAP-70. Down-modulation of the TCR at high
occupancy did not require ZAP-70, whereas at low TCR occupancy
down-modulation was markedly reduced in the absence of ZAP-70 and in
cells expressing a dead kinase mutant of ZAP-70. Thus, the presence of
ZAP-70 alone is not sufficient for down-modulation; the kinase activity
of this molecule is also required. The degradation of
induced by
TCR triggering is also severely impaired in T cells from
ZAP-70-deficient patients, P116 cells, and P116 cells expressing a
kinase-dead form of ZAP-70. This defect in TCR-induced
degradation
is observed at low and high levels of TCR occupancy. Our results
identify ZAP-70, a tyrosine kinase known to be crucial for T cell
activation, as a key player in TCR down-modulation and
degradation.
This article has been cited by other articles:
![]() |
F. Rieux-Laucat, C. Hivroz, A. Lim, V. Mateo, I. Pellier, F. Selz, A. Fischer, and F. Le Deist Inherited and somatic CD3zeta mutations in a patient with T-cell deficiency. N. Engl. J. Med., May 4, 2006; 354(18): 1913 - 1921. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Davanture, J. Leignadier, P. Milani, P. Soubeyran, B. Malissen, M. Malissen, A.-M. Schmitt-Verhulst, and C. Boyer Selective Defect in Antigen-Induced TCR Internalization at the Immune Synapse of CD8 T Cells Bearing the ZAP-70(Y292F) Mutation J. Immunol., September 1, 2005; 175(5): 3140 - 3149. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Steinberg, O. Adjali, L. Swainson, P. Merida, V. D. Bartolo, L. Pelletier, N. Taylor, and N. Noraz T-cell receptor-induced phosphorylation of the {zeta} chain is efficiently promoted by ZAP-70 but not Syk Blood, August 1, 2004; 104(3): 760 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bommireddy, V. Saxena, I. Ormsby, M. Yin, G. P. Boivin, G. F. Babcock, R. R. Singh, and T. Doetschman TGF-{beta}1 Regulates Lymphocyte Homeostasis by Preventing Activation and Subsequent Apoptosis of Peripheral Lymphocytes J. Immunol., May 1, 2003; 170(9): 4612 - 4622. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |